Skip to content

Clinical trials

Phase 3 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 3 Clear all

203 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
200210
20033
20042
200510
200615
200714
200811
20099
201011
20118
20125
201313
20146
20158
20165
20177
201810
20199
20208
20216
20225
20237
20242
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed130
Terminated22
Unknown status19
Active, not recruiting12
Recruiting10
Withdrawn8
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen25
Jazz Pharmaceuticals14
Novartis Pharmaceuticals12
Sanofi9
Acorda Therapeutics6
Teva Branded Pharmaceutical Products R&D, Inc.6
Genzyme, a Sanofi Company5
Hoffmann-La Roche5
Novartis5
RVL Pharmaceuticals, Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis203
Multiple Sclerosis, Relapsing-Remitting43
Muscle Spasticity19
Recurrence13
Multiple Sclerosis, Chronic Progressive12
Demyelinating Diseases6
Pain6
Optic Neuritis5
Fatigue4
Neuralgia4

Trials

Showing 76 to 100 of 203. Each trial links to its page on Pharma Observatory.

103 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.